Skip to main content
VCbacked
Log inGet Started

Quell Therapeutics

London, United Kingdom

Quell Therapeutics is a cell therapy company

$156.0M raised
Nov 2021
Series B
AssociationBiotechnologyEducationHealth Care

Top Investors

Janus Henderson InvestorsPoint72Jeito CapitalSV Health InvestorsFidelity

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Quell Therapeutics

How much funding has Quell Therapeutics raised?
Quell Therapeutics has raised $156.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Who are Quell Therapeutics's investors?
Quell Therapeutics's investors include Janus Henderson Investors, Point72, Jeito Capital, SV Health Investors, Fidelity.
Where is Quell Therapeutics headquartered?
Quell Therapeutics is headquartered in London, United Kingdom.
What does Quell Therapeutics do?
Quell Therapeutics is a cell therapy company
What stage is Quell Therapeutics at?
Quell Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Quell Therapeutics — Funding & Investors." VCBacked, November 29, 2021, https://www.vcbacked.co/company/quell-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2021). Quell Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/quell-therapeutics
Wikipedia (cite web)
{{cite web |title=Quell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quell-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Association

View all
Joe Louis Greenway Partnership
Detroit$2.0M
Make-a-Wish Foundation
Phoenix
Center for Disaster Philanthropy
Washington$6.8M
Cabinet
New York$2.5M
School Board Partners
New Orleans$250K
Oxara
Dietikon